pH-Responsive Degradable Dextran-Quantum Dot Nanohybrids for Enhanced Gene Delivery.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• Developing safe and effective gene carriers is crucial for advanced therapies.
• Stimuli-responsive nanocarriers offer enhanced drug release and reduced toxicity.
• Integrating imaging capabilities facilitates real-time monitoring of therapeutic processes.

Purpose of the Study:

• To develop novel, biocompatible, and degradable nanohybrids for stimuli-enhanced gene therapy and imaging.
• To investigate the efficacy of pH-responsive dextran-quantum dot-polycation nanohybrids (DQ-PGEA) as gene carriers.
• To evaluate the in vivo performance of DQ-PGEA for breast cancer treatment.

Main Methods:

• Synthesis of dextran-quantum dot-polycation (PGEA) nanohybrids (DQ-PGEA) utilizing Schiff base linkages.
• Preparation of reduced, non-degradable DQ-PGEA-R nanohybrids as controls.
• In vivo evaluation of gene transfection, antitumor efficacy, and fluorescence imaging in a mouse model of breast cancer.

Main Results:

• DQ-PGEA nanohybrids exhibited low cytotoxicity, good stability, and biocompatibility.
• The pH-responsive Schiff base linkages facilitated enhanced gene release and carrier self-destruction.
• DQ-PGEA demonstrated superior gene transfection and antitumor inhibition compared to DQ-PGEA-R.
• Real-time fluorescence imaging confirmed efficient gene delivery and enabled imaging-guided therapy.

Conclusions:

• Stimuli-responsive DQ-PGEA nanohybrids represent a promising platform for enhanced gene therapy and imaging-guided cancer treatment.
• The self-destruction feature of DQ-PGEA contributes to improved therapeutic outcomes and carrier elimination.
• These multifunctional nanoplatforms hold significant potential for advancing tumor therapy.